7/29/2019 jhonson and jhonson by fuuast
1/26
7/29/2019 jhonson and jhonson by fuuast
2/26
PRESENTATORS
ASFANDYAR KHAN
FARHAN NIZAMIFAIZAN SHEIKH
FAIZ-UD-DIN
SANAULLAH KHAN
7/29/2019 jhonson and jhonson by fuuast
3/26
7/29/2019 jhonson and jhonson by fuuast
4/26
Overview of Johnson & JohnsonA Broadly Based Health Care
CompanyJohnson & Johnson is the worlds mostcomprehensiveandbroadly basedmanufacturer of health care products and
services for theconsumer, pharmaceutical,and medical & diagnosticsmarkets.
The Corporation achieved this leadership byconcentrating on a unique form ofdecentralized management, following theethical principles embodied in our Credoandmanaging the business for thelong term.
7/29/2019 jhonson and jhonson by fuuast
5/26
Overview
Headquartered in New Brunswick, NJ
Companies in 57 countries, selling products inmore than 175 countries
2011 sales were US$ 65 billion
Over 110,600 employees worldwide
Extensive worldwide research and supply
chain capabilities
More than US$280 million pa philanthropy
7/29/2019 jhonson and jhonson by fuuast
6/26
Founded in 1886.
Founded by :
ROBERT WOOD-1
JAMES WOOD JOHNSONEDWARD MEAD JPHNSON
7/29/2019 jhonson and jhonson by fuuast
7/26
This is the illustration of the fist building of johnson &johnson company
This factory was been set up beside the railroad
By 1907 , J&J expanded from a single building to 35 buildings .
By the same year 2500 employees were working .
7/29/2019 jhonson and jhonson by fuuast
8/26
Robert Wood Johnson-1 :1887-1910
James Wood Johnson :1910-1932
Robert Wood Johnson-2 :1932-1963
Philip B. Hofmann :1963-1973Richard B. Sellars :1973-1976
James E. Burke :1976-1989
Ralph S. Larsen :1989-2002William C. Weldon :2002-
7/29/2019 jhonson and jhonson by fuuast
9/26
Mission/Vision StatementJohnson & Johnson, a global
company, posts that "The fundamentalobjective of Johnson & Johnson is to
provide scientifically sound, highquality products and services to helpheal, cure disease and improve the
quality of life."
7/29/2019 jhonson and jhonson by fuuast
10/26
Sales Results By Segment
35% 17
%
47%Medical
Devices &Diagnostic
Consumer
Pharmaceutical
7/29/2019 jhonson and jhonson by fuuast
11/26
Consumer Health Care
Skin care Baby care
Wound care
Oral care Over-the-
Counter-Drugs
and Vitamins
7/29/2019 jhonson and jhonson by fuuast
12/26
Medical Devices & Diagnostics
Diabetes
Ortho-clinical
Chordis
Depuy Vision care
7/29/2019 jhonson and jhonson by fuuast
13/26
Pharmaceuticals
Duragesic
Risperdal 1
Risperdal 2
Concerta Topamax
Procrit
Aciphex
7/29/2019 jhonson and jhonson by fuuast
14/26
RoC BRILLIANCE
Starts working immediately to
reduce the appearance of dark
circles and puffiness and is
clinically proven to smooth andtighten the look of delicate skin
around the eyes.
NEUTROGENA Rapid Clear SorePimple Gel
Instantly cools to soothe sore
pimples and clinically proven to
reduce the size, redness and
swelling of sore pimples in just 8
hours.
7/29/2019 jhonson and jhonson by fuuast
15/26
Competitors
Abbott Laboratories:Abbott laboratories is engaged in discovery,development, manufacture and sale of avariety of health care products through fourbusiness segments: Pharmaceutical,Diagnostics, Nutritional and Vascular products.
Merck & Co. Inc.:A top competitor is Merck & Co. which offerstreatment and medication four adults andchildren over a wide range of application.Merck has a strong position in the world ofpharmaceutical with such advancements as
Gardasil, the world first anticancer vaccine,Diabetes medication eye disease treatmentand multiple Cardio Vascular drugs such asCozaar and Hyzaar.
7/29/2019 jhonson and jhonson by fuuast
16/26
Novartis:Novartis offer over 60 pharmaceutical products
including one of the most well known drugs,ritalin, and has received more approvals thanany other pharmaceutical company in theindustry since 2000
Pfizer:Pfizer has tow segments: Pharmaceutical, which
develops and produces products that treatcardio vasular and metabolic diseases, centralnervous system disorders, cancer, eye diseaseetc. and Animal Health, which disvovers,develops and sells products for the prevention
and treatment of diseases in livestock andcompanion animals.
7/29/2019 jhonson and jhonson by fuuast
17/26
STRATEGIES
Strategic AcquisitionsJohnson & Johnson has maintained a stable
financial position by utilizing cash reserves tofinance timely corporate acquisitions. Its Triple
A Credit Rating represents a company able to
take advantage of opportunities that arisewithout being limited by burdensome levels ofdebt.
7/29/2019 jhonson and jhonson by fuuast
18/26
Product Diversification
The Johnson & Johnson pharmaceutical portfolio,and ts large Medical Devices & Diagnostics (M,D&D) and Consumer Health divisions serves toreduce dependence upon any one area. The
company plans to continue this broadeningthrough 2008-14. This diversification allows awider range of choice when pursuing opportunitieswith the greatest growth prospects.
7/29/2019 jhonson and jhonson by fuuast
19/26
Positive RevenueGrowth Projections
The potential of an impressive number of new productlaunches and the promise of achieving forecastsales is said to bode well for Johnson & Johnson,helping it weather the recent decline in prescriptionpharmaceuticals and projecting a turn-around
through 2010. An increase at 1.8% CAGR across200814 is believed to be achievable.
7/29/2019 jhonson and jhonson by fuuast
20/26
Distribution Strategy
Currently all productpurchasing is online and
delivery is directly made to useraddress
7/29/2019 jhonson and jhonson by fuuast
21/26
SWOT Analysis Strengths:
Broad diversity of products. Not reliant on a soleproduct line for majority of revenue.
Repeat customers. People tend to be brand-loyal.If they buy Tylenol for their headaches, they tendto repeatedly buy Tylenol.
Strong brands. "No more tears" shampoo, Band-
Aid, Tylenol, Visine, etc. Generally smart purchasing of companies. For
instance, it didn't purchase
7/29/2019 jhonson and jhonson by fuuast
22/26
WEAKNESS A conglomerate of relatively independent
companies. Sometimes they can go off thereservation, such as what appears to havehappened with McNeil Consumer Healthcare andthe making of the children's medicine now beingrecalled.
Several of its big drugs have lost or will soon losepatent protection.
Many of its products are commodities. Forinstance, other adhesive bandages exist, not justBand-Aid.
OPPORTUNITIES Development of personalized drugs that work best
on specific genetic profiles, such as Gleevecfrom Novartis
Continued smart purchasing of companies withcomplementary products.
7/29/2019 jhonson and jhonson by fuuast
23/26
THREATS
Increasing pressure to move to generic drugs.
Stiff competition instants, especially from AbbottLabs , Boston Scientific, and Medtronic , andhaving to keep one step ahead of everyone else.
7/29/2019 jhonson and jhonson by fuuast
24/26
Environmental Analysis
Political factor
Economic factor
Socio-cultural factor
Technological factor
7/29/2019 jhonson and jhonson by fuuast
25/26
Future
Over the past two decades, Johnson & Johnsonhas continued to set and meet a series of long-term targets across a range of environmentalimpacts including Pollution Prevention Goals,Next Generation Goals, and its most recently
completed Healthy Planet 2010 Goals.. The nextstep in its evolution was to go bolder and broaderwith Healthy Planet 2015 Goals..
At the heart ofHealthy Planet 2015 Goalsare 15of the boldest and broadest sustainability goals wehave set to date and extend well beyondenvironmental stewardship to include an emphasison improving peoples health, increasing corporate
transparency and encouraging collaborativepartnerships.
7/29/2019 jhonson and jhonson by fuuast
26/26